Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
agilon health Inc (AGL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/16/2025: AGL (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
20 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $1.48
1 Year Target Price $1.48
| 4 | Strong Buy |
| 0 | Buy |
| 14 | Hold |
| 2 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -13.9% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/16/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 460.01M USD | Price to earnings Ratio - | 1Y Target Price 1.48 |
Price to earnings Ratio - | 1Y Target Price 1.48 | ||
Volume (30-day avg) 20 | Beta 0.12 | 52 Weeks Range 0.71 - 6.08 | Updated Date 09/16/2025 |
52 Weeks Range 0.71 - 6.08 | Updated Date 09/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.79 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -5.35% | Operating Margin (TTM) -8.31% |
Management Effectiveness
Return on Assets (TTM) -12.07% | Return on Equity (TTM) -60.68% |
Valuation
Trailing PE - | Forward PE 178.57 | Enterprise Value 157804769 | Price to Sales(TTM) 0.08 |
Enterprise Value 157804769 | Price to Sales(TTM) 0.08 | ||
Enterprise Value to Revenue 0.03 | Enterprise Value to EBITDA -104.52 | Shares Outstanding 414423008 | Shares Floating 286262790 |
Shares Outstanding 414423008 | Shares Floating 286262790 | ||
Percent Insiders 2.08 | Percent Institutions 93.38 |
Upturn AI SWOT
agilon health Inc
Company Overview
History and Background
Agilon Health was founded in 2016 and went public in April 2021. It focuses on enabling primary care physicians to transition to value-based care models by providing a technology and services platform that supports risk-bearing arrangements.
Core Business Areas
- Risk-Bearing Enablement: Provides a comprehensive platform that includes data and analytics, network management, and care coordination tools to support physicians in managing the health of their patient populations under full risk capitation agreements.
Leadership and Structure
The leadership team includes Steve Sell (CEO). The organizational structure is based on functional departments that support the various aspects of their risk-bearing enablement model.
Top Products and Market Share
Key Offerings
- Full-Risk Platform: Agilon Health's core product is a comprehensive platform enabling primary care physicians to shift to a full-risk, value-based care model. They provide technology, data analytics, care coordination, and network management services. Competitors include Privia Health (PRVA), and Oak Street Health (CVS).
Market Dynamics
Industry Overview
The healthcare industry is increasingly shifting towards value-based care models, with a greater emphasis on preventative care and cost efficiency. This is driven by rising healthcare costs and a desire for better patient outcomes.
Positioning
Agilon Health positions itself as a partner to primary care physicians, enabling them to succeed in value-based care arrangements. Their competitive advantage lies in their comprehensive platform and deep expertise in risk management.
Total Addressable Market (TAM)
The TAM for value-based care enablement is estimated to be substantial, with growing adoption of value-based care arrangements across the US. Agilon Health is positioned to capture a significant portion of this market.
Upturn SWOT Analysis
Strengths
- Comprehensive platform
- Expertise in risk management
- Strong relationships with primary care physicians
- Scalable business model
Weaknesses
- Reliance on a limited number of health plan partners
- Geographic concentration
- Potential for increased competition
- Capital intensive
Opportunities
- Expansion into new geographic markets
- Partnerships with additional health plans
- Acquisition of smaller players in the market
- Development of new service offerings
Threats
- Changes in healthcare regulations
- Increased competition from larger players
- Economic downturn impacting healthcare spending
- Failure to achieve projected growth rates
Competitors and Market Share
Key Competitors
- PRVA
- CVS
- ONE
Competitive Landscape
Agilon Health has a strong technology platform and is solely focused on risk based primary care which gives them an edge compared to its competitor. However its scale is smaller than many larger players like CVS and ONE.
Growth Trajectory and Initiatives
Historical Growth: Agilon Health has experienced rapid growth in recent years, driven by the increasing adoption of value-based care models.
Future Projections: Analysts project continued revenue growth for Agilon Health, driven by expansion into new markets and increased membership. Profitability is expected to improve over time as the company achieves greater scale.
Recent Initiatives: Recent strategic initiatives include expanding into new geographic markets, partnering with additional health plans, and investing in technology to enhance their platform.
Summary
Agilon Health is a growing company enabling value-based care for primary care physicians. The company has shown significant revenue growth and has a solid platform that is enabling it to be competitive, however, the company is not consistently profitable. Challenges include dependence on key relationships and geographical concentration, but opportunities exist via strategic acquisitions, partnerships, and development of new product offerings. Monitoring industry competition and changes in healthcare regulations is crucial.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual research and consultation with a financial professional.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About agilon health Inc
Exchange NYSE | Headquaters Westerville, OH, United States | ||
IPO Launch date 2021-04-15 | CEO - | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 1076 | Website https://www.agilonhealth.com |
Full time employees 1076 | Website https://www.agilonhealth.com | ||
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.